I know i have mentioned this before, and recently, but is a company with a P3 drug treating a condition with no approved treatments, favourable p3 parameters set by the FDA and a multi billion dollar end market worth $284m? I aint no Warren Buffet but i wouldnt think so.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$12.82 |
Change
-0.140(1.08%) |
Mkt cap ! $1.594B | |||
| Open | High | Low | Value | Volume |
| $12.82 | $13.05 | $12.53 | $5.783M | 451.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 14 | 791 | $12.82 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $12.83 | 130 | 5 |
View Market Depth
| Last trade - 15.58pm 17/06/2025 (20 minute delay) ? |
| NEU (ASX) Chart |